HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daniel San-Juan Selected Research

Migraine Disorders (Migraine)

1/2021Evidence-Based Guidelines and Secondary Meta-Analysis for the Use of Transcranial Direct Current Stimulation in Neurological and Psychiatric Disorders.
2/2012Peripheral pulsed electromagnetic fields may reduce the placebo effect in migraine patients that do not respond to the sham intervention in a randomized, placebo-controlled, double-blind, cross-over clinical trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daniel San-Juan Research Topics

Disease

10Epilepsy (Aura)
01/2022 - 05/2015
5Seizures (Absence Seizure)
05/2021 - 01/2016
4Drug Resistant Epilepsy
11/2021 - 01/2017
3Status Epilepticus (Complex Partial Status Epilepticus)
07/2019 - 01/2016
2Migraine Disorders (Migraine)
01/2021 - 02/2012
2Temporal Lobe Epilepsy
01/2020 - 01/2017
1Lennox Gastaut Syndrome
08/2022
1Erythema
08/2022
1Pruritus (Itching)
08/2022
1Anti-N-Methyl-D-Aspartate Receptor Encephalitis
11/2021
1Partial Epilepsies (Epilepsy, Partial)
05/2021
1Pain (Aches)
01/2021
1Alcoholism (Alcohol Abuse)
01/2021
1Acute Pain
01/2021
1Stroke (Strokes)
01/2021
1Mental Disorders (Mental Disorder)
01/2021
1Substance-Related Disorders (Drug Abuse)
01/2021
1Depressive Disorder (Melancholia)
01/2021
1Tonic-Clonic Epilepsy (Epilepsy, Tonic Clonic)
01/2021
1Fibromyalgia (Fibrositis)
01/2021
1Tourette Syndrome (Tourette's Syndrome)
01/2021
1Schizophrenia (Dementia Praecox)
01/2021
1Neuralgia (Stump Neuralgia)
01/2021
1Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive)
01/2021
1Parkinson Disease (Parkinson's Disease)
01/2021
1Mood Disorders (Mood Disorder)
01/2020
1Malformations of Cortical Development
01/2018
1Focal Cortical Dysplasia
01/2018
1Neoplasms (Cancer)
10/2017
1Hippocampal Sclerosis
01/2017
1Cysts
09/2016
1Juvenile Myoclonic Epilepsy
01/2016
1Generalized Epilepsy
01/2016
1Encephalitis (Encephalitis, Rasmussen)
01/2011

Drug/Important Bio-Agent (IBA)

2Anticonvulsants (Antiepileptic Drugs)IBA
01/2018 - 01/2016
1Glutamic Acid (Glutamate)FDA Link
11/2021
1Pharmaceutical PreparationsIBA
05/2021
1Neuroprotective AgentsIBA
01/2020
1CannabinoidsIBA
01/2020
1Proteins (Proteins, Gene)FDA Link
01/2020
1Messenger RNA (mRNA)IBA
01/2020
1EndocannabinoidsIBA
01/2020
1Fentanyl (Sublimaze)FDA LinkGeneric
07/2017
1Propofol (Diprivan)FDA LinkGeneric
07/2017
1AnthelminticsIBA
09/2016
1Clonazepam (Rivotril)FDA LinkGeneric
01/2016
1Valproic Acid (Depakote)FDA LinkGeneric
01/2016
1salicylhydroxamic acid (SHAM)IBA
02/2012

Therapy/Procedure

13Transcranial Direct Current Stimulation
08/2022 - 01/2011
7Therapeutics
11/2021 - 05/2015
1Patient-Controlled Analgesia (Analgesia, Patient Controlled)
01/2021
1Vagus Nerve Stimulation
07/2019
1Deep Brain Stimulation
07/2019
1Transcranial Magnetic Stimulation
07/2019
1Eye Protective Devices (Goggles)
10/2017
1Anesthesia
07/2017
1Aftercare (After-Treatment)
01/2017